Article

Stereotactic interstitial irradiation of diencephalic tumors with iridium 192 and iodine 125: 10 years follow-up and comparison with other treatments.

Neurochirurgische Universitätsklinik Freiburg, Abteilung Stereotaxie und Neuronuklearmedizin, Federal Republic of Germany.
Child s Nervous System (impact factor: 1.54). 07/1989; 5(3):140-3. pp.140-3
Source: PubMed

ABSTRACT The only possible treatment of non-removable tumors of the diencephalon or recurring tumors invading the diencephalon after partial resection or percutaneous radiotherapy is interstitial irradiation (Curie therapy). With the CT/MRI stereotactic method, biopsy for histological tumor classification can be performed and 125I or 192Ir implanted, provided the neuroimaging methods show the delimitation of the tumor, its diameter does not exceed 3 cm and, given the patient's condition, focal irradiation seems advisable. As of 31 August 1987, a total of 1883 cases had been stereotactically biopsied and interstitially irradiated. The indications and results are reported in 204 patients under 18 years of age with diencephalic and deep-seated astrocytomas, after a follow-up period of up to 10 years; the data were compared for tumor resection, percutaneous irradiation, and for interstitial irradiation. The latter proved to be the most effective treatment.

0 0
 · 
0 Bookmarks
 · 
9 Views
  • Source
    Article: Iodine-125 brachytherapy for brain tumours--a review.
    Silke B Schwarz, Niklas Thon, Katharina Nikolajek, Maximilian Niyazi, Joerg-Christian Tonn, Claus Belka, Friedrich-Wilhelm Kreth
    [show abstract] [hide abstract]
    ABSTRACT: Iodine-125 brachytherapy has been applied to brain tumours since 1979. Even though the physical and biological characteristics make these implants particularly attractive for minimal invasive treatment, the place for stereotactic brachytherapy is still poorly defined.An extensive review of the literature has been performed, especially concerning indications, results and complications. Iodine-125 seeds have been implanted in astrocytomas I-III, glioblastomas, metastases and several other tumour entities. Outcome data given in the literature are summarized. Complications are rare in carefully selected patients.All in all, for highly selected patients with newly diagnosed or recurrent primary or metastatic tumours, this method provides encouraging survival rates with relatively low complication rates and a good quality of life.
    Radiation Oncology 03/2012; 7:30. · 2.32 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

192Ir implanted
 
advisable
 
CT/MRI stereotactic method
 
deep-seated astrocytomas
 
diencephalic
 
diencephalon
 
follow-up period
 
histological tumor classification
 
interstitial irradiation
 
interstitially irradiated
 
neuroimaging methods
 
non-removable tumors
 
partial resection
 
patient's condition
 

A Etou